We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are primarily conducted in the United States. It focuses to develop, u... Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are primarily conducted in the United States. It focuses to develop, use, manufacture, commercialize, sublicense and distribute a clinical-stage and follow-on small molecule drug program and a preclinical stage bioconjugation/next-generation ADC platform. Show more
VIP943 demonstrates promising safety and tolerability and achieves two complete responses to date in Phase 1 dose-escalation study, reinforcing the programβs potential and validating the VersAptxβ’...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0402 | -10.3875968992 | 0.387 | 0.4098 | 0.33 | 404249 | 0.36322702 | CS |
4 | -0.3732 | -51.8333333333 | 0.72 | 0.76 | 0.33 | 1176500 | 0.46554562 | CS |
12 | -0.2491 | -41.8023158248 | 0.5959 | 0.85 | 0.33 | 525922 | 0.52507217 | CS |
26 | -0.4732 | -57.7073170732 | 0.82 | 0.935 | 0.33 | 347254 | 0.5825654 | CS |
52 | -0.5997 | -63.3597464342 | 0.9465 | 9.3722 | 0.33 | 602997 | 1.94206981 | CS |
156 | -13.8532 | -97.5577464789 | 14.2 | 15.285 | 0.33 | 281186 | 2.09767125 | CS |
260 | -19.7732 | -98.2763419483 | 20.12 | 26.75 | 0.33 | 245342 | 3.60564736 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions